Uncover the power of circulating protein biomarkers in disease research

Circulating protein biomarkers have immense clinical value, as they reveal real-time biological insights, identify clinical phenotypes and support drug development in a non-invasive, robust, and efficient manner. Successful discovery and implementation of comprehensive blood biomarker signatures will rely on immunoassays that allow scalable multiplexing with consistently high data quality.

Olink Flex allows customization of protein biomarker panels without compromising on data quality, by leveraging the exceptional specificity and sensitivity of the Proximity extension assay technology. Users are free to mix and match protein biomarkers into a single panel from a comprehensive library of validated assays or choose one of our pre-designed panels covering immuno-oncology, IFN stimulation or cytokine storm.

Download the information sheets

Take a deep dive into how our carefully designed biomarker panels are accelerating clinical breakthroughs in the fields of oncology and immune-related diseases.

Discover how circulating immune biomarkers are enhancing cancer patient stratification and drug development.

Unveiling the blood IFN signature as a key predictor of immunotherapy resistance and clinical outcome in cancer.

Learn how cytokine profiling can reveal cytokine storm disease mechanisms, aid early prognosis, and foster personalized treatments.

Download all three information sheets

Explore the application of circulating biomarker in Immuno-oncology, IFN stimulation and cytokine storm research.

Learn more about how Olink solutions can accelerate disease research and drive new therapies

See how Olink® Flex and our other inflammatory protein assays provide actionable insights across a broad range of diseases.

Olink’s highly flexible made-to-order product, Olink® Flex, enables you to select and combine targets for up to 21 human proteins in one biomarker panel.

Olink offers high-quality protein biomarker discovery based on a flexible and scalable technology platform.

Get in touch with us!